Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
HKSE - Delayed Quote HKD

Clover Biopharmaceuticals, Ltd. (2197.HK)

Compare
0.216
-0.007
(-3.14%)
At close: April 3 at 3:51:25 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
39,255
39,255
--
--
--
Cost of Revenue
15,014
15,014
--
--
--
Gross Profit
24,241
24,241
--
--
--
Operating Expense
896,331
896,331
1,861,152
2,157,785
284,289
Operating Income
-872,090
-872,090
-1,861,152
-2,157,785
-284,289
Net Non Operating Interest Income Expense
-2,605
-2,605
2,577
2,674
435
Pretax Income
-138,539
-138,539
-2,451,903
-6,016,303
-912,898
Net Income Common Stockholders
-138,539
-138,539
-2,451,903
-6,016,303
-912,898
Diluted NI Available to Com Stockholders
-138,539
-138,539
-2,451,903
-6,016,303
-912,898
Basic EPS
-0.65
-0.11
-2.22
-13.02
-0.79
Diluted EPS
-0.65
-0.11
-2.22
-13.02
-0.79
Basic Average Shares
1,179,166.490
1,243,504.146
1,102,103.513
462,117.327
1,158,114.723
Diluted Average Shares
1,182,010.185
1,243,504.146
1,102,103.513
462,117.327
1,158,114.723
Total Expenses
911,345
911,345
1,861,152
2,157,785
284,289
Net Income from Continuing & Discontinued Operation
-138,539
-138,539
-2,451,903
-6,016,303
-912,898
Normalized Income
1,621,636
1,621,636
-1,898,741
-6,017,211
-912,898
Interest Income
16,118
16,118
8,507
10,890
3,408
Interest Expense
18,723
18,723
5,930
2,520
1,657
Net Interest Income
-2,605
-2,605
2,577
2,674
435
EBIT
-119,816
-119,816
-2,445,973
-6,013,783
-911,241
EBITDA
-45,074
-45,074
-2,385,879
-5,988,394
-905,457
Reconciled Cost of Revenue
15,014
15,014
--
--
--
Reconciled Depreciation
74,742
74,742
60,094
25,389
5,784
Net Income from Continuing Operation Net Minority Interest
-138,539
-138,539
-2,451,903
-6,016,303
-912,898
Total Unusual Items Excluding Goodwill
-1,760,175
-1,760,175
-553,162
908
--
Total Unusual Items
-1,760,175
-1,760,175
-553,162
908
--
Normalized EBITDA
1,715,101
1,715,101
-1,832,717
-5,989,302
-905,457
12/31/2020 - 11/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6660.HK AIM Vaccine Co., Ltd.
4.000
-1.72%
 
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
27.400
-0.72%
 
2257.HK Sirnaomics Ltd.
3.450
0.00%
 
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.630
-7.91%
 
2157.HK Lepu Biopharma Co., Ltd.
3.980
-2.93%
 
9966.HK Alphamab Oncology
7.910
-4.70%
 
9939.HK Kintor Pharmaceutical Limited
1.320
-2.94%
 
1228.HK CANBRIDGE-B
0.144
-2.04%
 
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
55.750
-4.37%
 
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
309.000
-0.77%